Wird geladen...

Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D

BACKGROUND: Clinical guidelines recommend that women with hormone-receptor positive breast cancer receive endocrine therapy (selective estrogen receptor modulators [SERMs] or aromatase inhibitors [AIs]) for five years following diagnosis. OBJECTIVE: To examine utilization and adherence to therapy fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Riley, Gerald F., Warren, Joan L., Harlan, Linda C., Blackwell, Steven A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Centers for Medicare & Medicaid Services 2011
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4010443/
https://ncbi.nlm.nih.gov/pubmed/22340780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5600/mmrr.001.04.a04
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!